|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 5/00 | (2006.01) |
| (11) | Number of the document | 2714740 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12729030.2 |
| Date of filing the European patent application | 2012-05-31 | |
| (97) | Date of publication of the European application | 2014-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-30 |
| (46) | Date of publication of the claims translation | 2016-06-10 |
| (86) | Number | PCT/EP2012/060078 |
| Date | 2012-05-31 |
| (87) | Number | WO 2012/163932 |
| Date | 2012-12-06 |
| (30) | Number | Date | Country code |
| 11168644 | 2011-06-03 | EP |
| (72) |
FREIBERG, Christoph, DE
OTTO, Christiane, DE
LINDEN, Lars, DE
HARRENGA, Axel, DE
TRAUTWEIN, Mark, DE
GREVEN, Simone, DE
WILMEN, Andreas, DE
|
| (73) |
Bayer Intellectual Property GmbH ,
Alfred-Nobel Strasse 50, 40789 Monheim an Rhein,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Neutralizuojantis prolaktino receptoriaus antikūnas MAT3 ir jo terapinis panaudojimas |
| NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 14 | 289.00 EUR |
| 2026-05-31 |